Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Corporate News: Rubean AG (EQS) +++ RUBEAN Aktie +6,00%

ZIMMER BIOMET Aktie

 >ZIMMER BIOMET Aktienkurs 
83.06 EUR    -7.6%    (Tradegate)
Ask: 82.98 EUR / 40 Stück
Bid: 81.92 EUR / 50 Stück
Tagesumsatz: 13 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>ZIMMER BIOMET Performance
1 Woche: +1,1%
1 Monat: +3,2%
3 Monate: +10,6%
6 Monate: -1,8%
1 Jahr: -11,1%
laufendes Jahr: -13,1%
>ZIMMER BIOMET Aktie
Name:  ZIMMER BIOMET HLDGS DL-01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98956P1021 / 753718
Symbol/ Ticker:  ZIM (Frankfurt) / ZBH (NYSE)
Kürzel:  FRA:ZIM, ETR:ZIM, ZIM:GR, NYSE:ZBH
Index:  S&P500
Webseite:  https://www.zimmerbiomet...
Profil:  Zimmer Biomet Holdings, Inc. is a leading global m..
>Volltext..
Marktkapitalisierung:  17219.44 Mio. EUR
Unternehmenswert:  23197.18 Mio. EUR
Umsatz:  6817.69 Mio. EUR
EBITDA:  2167.03 Mio. EUR
Nettogewinn:  716.42 Mio. EUR
Gewinn je Aktie:  3.59 EUR
Schulden:  6590.28 Mio. EUR
Liquide Mittel:  484.67 Mio. EUR
Operativer Cashflow:  1447.3 Mio. EUR
Bargeldquote:  0.21
Umsatzwachstum:  -5.34%
Gewinnwachstum:  -24.92%
Dividende je Aktie:  0.82 EUR
Dividendenrendite:  0.96%
Dividendenschätzung:  0.96%
Div. Historie:  30.09.25 - 0.20592€
26.06.25 - 0.20592€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ZIMMER BIOMET
Letzte Datenerhebung:  05.11.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 198.1 Mio. St.
Frei handelbar: 99.86%
Rückkaufquote: 4.39%
Mitarbeiter: 17000
Umsatz/Mitarb.: 0.39 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 8.08%
Bewertung:
KGV: 25.35
KGV lG: 12.47
KUV: 2.59
KBV: 1.64
PEG-Ratio: -
EV/EBITDA: 10.7
Rentabilität:
Bruttomarge: 62.36%
Gewinnmarge: 10.51%
Operative Marge: 18.5%
Managementeffizenz:
Gesamtkaprendite: 3.71%
Eigenkaprendite: 6.52%
 >Anleihen 
Es sind 3 Anleihen zur ZIMMER BIOMET Aktie bekannt.
>Peer Group

Es sind 597 Aktien bekannt.
 
05.11.25 - 13:12
 Zimmer Biomet Holdings Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) released earnings for third quarter that Decreased from the same period last year but beat the Street estimates.The company's earnings came......
05.11.25 - 12:36
 Zimmer Biomet Non-GAAP EPS of $1.90 beats by $0.04, revenue of $2B misses by $10M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 12:33
 Zimmer Biomet Announces Third Quarter 2025 Financial Results (PR Newswire)
 
Third quarter net sales of $2.001 billion increased 9.7% on a reported basis, 8.6% on a constant currency1 basis and 5.0% on an organic constant currency1 basis Third quarter diluted earnings per share were $1.16; adjusted1 diluted earnings per share were $1.90, an increase of 9.2% For......
04.11.25 - 18:03
 Zimmer Biomet Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.10.25 - 14:09
 Zimmer Biomet gets FDA breakthrough status for hip replacement device (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.10.25 - 14:00
 Zimmer Biomet Receives FDA Breakthrough Device Status For Iodine-Treated Hip Replacement System (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, said Tuesday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation f......
28.10.25 - 12:33
 Zimmer Biomet Announces FDA Breakthrough Designation for World′s First Iodine-Treated Total Hip Replacement System (PR Newswire)
 
Prioritized Regulatory Review Process in the U.S. Follows Japan PMDA Approval in September WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has......
21.10.25 - 21:09
 PIH Health Revolutionizing Orthopedic Surgery with OrthoGrid Hip AI®: The Power of Artificial Intelligence and Real-time Data (PR Newswire)
 
WHITTIER, Calif., Oct. 21, 2025 /PRNewswire/ -- PIH Health is excited to offer patients undergoing a Total Hip Replacement the latest technology from Zimmer Biomet, OrthoGrid Hip AI®. OrthoGrid Hip AI empowers PIH Health hip replacement surgeons with a non-invasive, intuitive technology......
21.10.25 - 13:33
 Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting (PR Newswire)
 
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram Technologies WARSAW, Ind., Oct. 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical......
13.10.25 - 15:54
 Zimmer Biomet Earnings Preview: What to Expect (Barchart)
 
Zimmer Biomet is set to post its third-quarter results next month, and analysts project a single-digit earnings rise....
10.10.25 - 16:00
 The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock (Zacks)
 
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches....
08.10.25 - 14:12
 Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) and its subsidiary Paragon 28 on Wednesday announced the commercial launch of two new products for complex foot and ankle trauma: the Goril......
08.10.25 - 13:33
 Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases (PR Newswire)
 
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and......
07.10.25 - 16:27
 Zimmer Biomet closes acquisition of Monogram Technologies (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.10.25 - 15:54
 Zimmer Biomet Completes Acquisition Of Monogram (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH) has completed the acquisition of Monogram Technologies, an AI-driven, next-generation orthopedic robotics company. The acquisition expands......
03.10.25 - 17:30
 Are Investors Undervaluing Zimmer Biomet (ZBH) Right Now? (Zacks)
 
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks....
03.10.25 - 13:33
 Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results (PR Newswire)
 
WARSAW, Ind., Oct. 3, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that......
02.10.25 - 17:30
 ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7 (Zacks)
 
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology....
29.09.25 - 23:54
 XFRA: DIVIDEND/INTEREST INFORMATION - 30.09.2025 - US98956P1021 (XETRA)
 
Das Instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY wird ex Dividende/Zinsen gehandelt am 30.09.2025 The instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY has its ex-dividend/interest day on 30.09.2025...
29.09.25 - 16:00
 ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now? (Zacks)
 
ISRG and ZBH both push robotics forward, but valuation and Zacks Rank tilt near-term upside toward Zimmer Biomet. Which one offers a better bet?...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!